1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Williams, M.A. Feeney, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE FEBS Lett. FEBLAL 0165 0014-5793 493 70 10.1016/S0014-5793(01)02276-1 11286998 The Solution Structure of the Disulphide-Linked Dimeric of the Human Trefoil Protein Tff1 2001 UK J.Mol.Biol. JMOBAK 0070 0022-2836 267 418 10.1006/JMBI.1997.0896 9096235 High-Resolution Solution Structure of Human Pnr-2/ Ps2: A Single Trefoil Motif Protein 1997 UK Biochem.J. BIJOAK 0043 0264-6021 327 117 9355742 Homodimerization and Hetero_Oligomerization of the Single Domain Trefoil Protein Pnr-2/Ps2 Through Cysteine 58 1997 UK Biochem.J. BIJOAK 0043 0264-6021 308 1001 8948462 Production and Comparison of Mature Single-Domain 'Trefoil' Peptides Pnr-2/Ps2 Cys58 and Pnr-2/Ps2 Ser58 1995 IX Eur.J.Biochem. EJBCAI 0262 0014-2956 233 847 10.1111/J.1432-1033.1995.847_3.X 8521850 NMR-Based Structural Studies of the Pnr-2/Ps2 Single Domain Trefoil Peptide. Similarities to Porcine Spasmolytic Peptide and Evidence for a Monomeric Structure 1995 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 DISULPHIDE LINK BETWEEN C58 OF BOTH SUBUNITS 6678.365 PS2 PROTEIN 2 man polymer PNR-2, PS2, TFF1, BREAST CANCER ESTROGEN INDUCIBLE PROTEIN, TREFOIL FACTOR FAMILY 1 PROTEIN no no EAQTETCTVAPRERQNCGFPGVTPSQCANKGCCFDDTVRGVPWCFYPNTIDVPPEEECEF EAQTETCTVAPRERQNCGFPGVTPSQCANKGCCFDDTVRGVPWCFYPNTIDVPPEEECEF A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN EPITHELIAL sample MCF-7, UACL EXTRACELLULAR TFF1 9606 BREAST, STOMACH HOMO SAPIENS CYTOPLASM TFF1 634468 ESCHERICHIA COLI HB101 PHARMACIA PEZZ18 PLASMID pdbx_nmr_representative entity_src_gen repository Initial release Version format compliance Version format compliance Structure summary Data collection Source and taxonomy 1 0 2001-01-03 1 1 2011-05-08 1 2 2011-07-13 1 3 2017-06-14 1 4 2019-04-10 _pdbx_nmr_representative.conformer_id _entity_src_gen.pdbx_host_org_cell_line _entity_src_gen.pdbx_host_org_ncbi_taxonomy_id _entity_src_gen.pdbx_host_org_scientific_name HIGH RESOLUTION NMR SOLUTION STRUCTURE OF HUMAN PS2, 19 STRUCTURES PDBE Y PDBE 2001-01-03 REL 1PS2 SWS P04155 1 - 24 NOT IN ATOMS LIST THE STRUCTURE WAS DETERMINED USING TWO AND THREE DIMENSIONAL NMR EXPERIMENTS ON, RESPECTIVELY, UNLABELLED AND N-15 LABELLED TFF1 DIMER PROTEIN. MANY ASSIGN WERE MADE BY MAKING USE IF THE BETTER RESOLVED MONOMER SPECTRA (POLSHAKOV ET AL. 1995,1997) TOTAL NOE CONSTRAINT VIOLATIONS < 1.0 A 11 10 2-D 1H-1H HOMONUCLEAR TOCSY ROESY NOESY 1H/15N HSQC HSQC-NOESY 0.01 5.9 pH 1 atm 298 K REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE simulated annealing 6 BRUNGER refinement CNS 1.0 structure solution CNS 1.0 500 Varian UNITY 600 Varian UNITYPLUS GLU 1 n 1 GLU 1 A ALA 2 n 2 ALA 2 A GLN 3 n 3 GLN 3 A THR 4 n 4 THR 4 A GLU 5 n 5 GLU 5 A THR 6 n 6 THR 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A VAL 9 n 9 VAL 9 A ALA 10 n 10 ALA 10 A PRO 11 n 11 PRO 11 A ARG 12 n 12 ARG 12 A GLU 13 n 13 GLU 13 A ARG 14 n 14 ARG 14 A GLN 15 n 15 GLN 15 A ASN 16 n 16 ASN 16 A CYS 17 n 17 CYS 17 A GLY 18 n 18 GLY 18 A PHE 19 n 19 PHE 19 A PRO 20 n 20 PRO 20 A GLY 21 n 21 GLY 21 A VAL 22 n 22 VAL 22 A THR 23 n 23 THR 23 A PRO 24 n 24 PRO 24 A SER 25 n 25 SER 25 A GLN 26 n 26 GLN 26 A CYS 27 n 27 CYS 27 A ALA 28 n 28 ALA 28 A ASN 29 n 29 ASN 29 A LYS 30 n 30 LYS 30 A GLY 31 n 31 GLY 31 A CYS 32 n 32 CYS 32 A CYS 33 n 33 CYS 33 A PHE 34 n 34 PHE 34 A ASP 35 n 35 ASP 35 A ASP 36 n 36 ASP 36 A THR 37 n 37 THR 37 A VAL 38 n 38 VAL 38 A ARG 39 n 39 ARG 39 A GLY 40 n 40 GLY 40 A VAL 41 n 41 VAL 41 A PRO 42 n 42 PRO 42 A TRP 43 n 43 TRP 43 A CYS 44 n 44 CYS 44 A PHE 45 n 45 PHE 45 A TYR 46 n 46 TYR 46 A PRO 47 n 47 PRO 47 A ASN 48 n 48 ASN 48 A THR 49 n 49 THR 49 A ILE 50 n 50 ILE 50 A ASP 51 n 51 ASP 51 A VAL 52 n 52 VAL 52 A PRO 53 n 53 PRO 53 A PRO 54 n 54 PRO 54 A GLU 55 n 55 GLU 55 A GLU 56 n 56 GLU 56 A GLU 57 n 57 GLU 57 A CYS 58 n 58 CYS 58 A GLU 59 n 59 GLU 59 A PHE 60 n 60 PHE 60 A GLU 1 n 1 GLU 1 B ALA 2 n 2 ALA 2 B GLN 3 n 3 GLN 3 B THR 4 n 4 THR 4 B GLU 5 n 5 GLU 5 B THR 6 n 6 THR 6 B CYS 7 n 7 CYS 7 B THR 8 n 8 THR 8 B VAL 9 n 9 VAL 9 B ALA 10 n 10 ALA 10 B PRO 11 n 11 PRO 11 B ARG 12 n 12 ARG 12 B GLU 13 n 13 GLU 13 B ARG 14 n 14 ARG 14 B GLN 15 n 15 GLN 15 B ASN 16 n 16 ASN 16 B CYS 17 n 17 CYS 17 B GLY 18 n 18 GLY 18 B PHE 19 n 19 PHE 19 B PRO 20 n 20 PRO 20 B GLY 21 n 21 GLY 21 B VAL 22 n 22 VAL 22 B THR 23 n 23 THR 23 B PRO 24 n 24 PRO 24 B SER 25 n 25 SER 25 B GLN 26 n 26 GLN 26 B CYS 27 n 27 CYS 27 B ALA 28 n 28 ALA 28 B ASN 29 n 29 ASN 29 B LYS 30 n 30 LYS 30 B GLY 31 n 31 GLY 31 B CYS 32 n 32 CYS 32 B CYS 33 n 33 CYS 33 B PHE 34 n 34 PHE 34 B ASP 35 n 35 ASP 35 B ASP 36 n 36 ASP 36 B THR 37 n 37 THR 37 B VAL 38 n 38 VAL 38 B ARG 39 n 39 ARG 39 B GLY 40 n 40 GLY 40 B VAL 41 n 41 VAL 41 B PRO 42 n 42 PRO 42 B TRP 43 n 43 TRP 43 B CYS 44 n 44 CYS 44 B PHE 45 n 45 PHE 45 B TYR 46 n 46 TYR 46 B PRO 47 n 47 PRO 47 B ASN 48 n 48 ASN 48 B THR 49 n 49 THR 49 B ILE 50 n 50 ILE 50 B ASP 51 n 51 ASP 51 B VAL 52 n 52 VAL 52 B PRO 53 n 53 PRO 53 B PRO 54 n 54 PRO 54 B GLU 55 n 55 GLU 55 B GLU 56 n 56 GLU 56 B GLU 57 n 57 GLU 57 B CYS 58 n 58 CYS 58 B GLU 59 n 59 GLU 59 B PHE 60 n 60 PHE 60 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N THR 6 A N THR 6 A O ASN 48 A O ASN 48 A N CYS 33 A N CYS 33 A O PHE 45 A O PHE 45 B N THR 6 B N THR 6 B O ASN 48 B O ASN 48 B N CYS 33 B N CYS 33 B O PHE 45 B O PHE 45 1 B B HG1 HB THR ILE 4 50 1.25 1 B B HB HD2 THR PRO 23 24 1.27 1 B B HG23 H THR CYS 6 7 1.28 1 B B HB2 HD2 PRO PRO 53 54 1.30 1 A A HG23 H THR THR 6 8 1.32 1 B B HA OG1 THR THR 6 49 1.53 1 B B HG1 O THR ILE 4 50 1.59 1 B B O HG22 GLU THR 5 49 1.59 1 B B O ND2 THR ASN 6 48 2.02 1 B B OG1 O THR ILE 4 50 2.12 2 A A H HD3 VAL PRO 52 53 1.12 2 A A HG23 H THR THR 6 8 1.23 2 B B HG3 H GLU GLU 56 57 1.26 2 A A HB HD2 THR PRO 23 24 1.26 2 A A HG2 H GLU CYS 57 58 1.27 2 B B HD2 H PHE GLY 19 21 1.34 3 B B HB3 HE22 GLU GLN 1 3 1.31 3 A A HZ HE22 PHE GLN 19 26 1.33 3 A A HB HD2 THR PRO 23 24 1.34 3 A A HD22 O ASN GLY 16 18 1.58 4 B B HG21 H THR THR 6 8 1.25 4 B B HG21 HD22 VAL ASN 9 48 1.27 4 A A HD2 HD3 PRO PRO 53 54 1.27 4 A A HH11 HG2 ARG GLU 12 13 1.31 4 B B HG3 H GLU CYS 57 58 1.34 5 B B HA H THR ILE 4 50 1.05 5 B B H HB GLN ILE 3 50 1.19 5 A A HG1 HG23 THR THR 6 8 1.26 5 A A H HB2 THR GLN 23 26 1.27 5 B B HB2 HD3 ALA PRO 2 53 1.31 5 B B H H THR ASN 6 48 1.31 5 A A HG23 HD22 VAL ASN 9 48 1.33 5 B B HD22 H ASN GLY 16 18 1.33 5 B B HH22 HG23 ARG VAL 14 38 1.34 5 B B HD21 N ASN CYS 16 17 1.48 5 B B ND2 H ASN GLY 16 18 1.51 5 A A OD1 H ASN GLY 16 18 1.56 5 B B O H ALA ARG 10 14 1.59 5 B B O O THR ASN 4 48 2.00 5 B B O N GLN ILE 3 50 2.13 5 A A OE1 OE1 GLU GLN 1 3 2.17 6 B B H HD3 VAL PRO 52 53 1.22 6 A A HG1 HE21 THR GLN 23 26 1.24 6 B B HG13 H VAL ALA 9 10 1.33 6 B B HG21 HD22 VAL ASN 9 48 1.34 6 B B HG2 H GLU CYS 57 58 1.35 6 B B HE22 HB3 GLN ASP 3 51 1.35 6 A A OD1 H ASN GLY 16 18 1.51 6 B B O H CYS LYS 27 30 1.59 6 B B NE2 OD1 GLN ASP 3 51 2.09 6 A A OD1 OG1 ASP THR 35 37 2.18 7 A A HG21 H THR THR 6 8 1.21 7 A A HG23 HD22 VAL ASN 9 48 1.25 7 B B HB HD2 THR PRO 23 24 1.25 7 B B H HE22 ALA GLN 2 3 1.27 7 B B HD21 N ASN CYS 16 17 1.50 7 A A N O GLY CYS 18 44 2.18 8 B B H HE21 THR GLN 23 26 1.17 8 A A HG3 HD12 GLU ILE 5 50 1.26 8 B B HD22 H ASN GLY 16 18 1.31 8 B B HG21 H THR THR 6 8 1.31 8 B B HD21 N ASN CYS 16 17 1.49 8 B B ND2 H ASN GLY 16 18 1.52 8 B B O H GLN ASN 26 29 1.53 8 B B O HZ1 GLN LYS 26 30 1.55 9 A A HB2 HD2 PHE PRO 19 20 1.18 9 B B HG21 H THR THR 6 8 1.24 9 A A H1 HB3 GLU PRO 1 53 1.29 9 A A HA HE22 GLU GLN 1 3 1.34 9 A A HG23 HD22 VAL ASN 9 48 1.35 9 B B OD1 H ASN GLY 16 18 1.49 9 A A OD1 H ASN GLY 16 18 1.55 10 A A HE21 HA GLN ASP 3 51 1.13 10 A A HB3 HA GLN ASP 3 51 1.29 10 A A H HD3 VAL PRO 52 53 1.30 10 B B H HD3 VAL PRO 52 53 1.30 10 B B HB2 HD2 PHE PRO 19 20 1.31 10 B B HB HD2 THR PRO 23 24 1.31 10 A A OD1 H ASN GLY 16 18 1.51 1 A PHE 19 -44.88 163.88 1 A PRO 47 -71.68 -161.63 1 A GLU 55 -169.95 -19.77 1 A GLU 56 -165.66 -29.52 1 A GLU 57 -150.78 -139.64 1 B ALA 2 -115.48 -132.84 1 B THR 4 -138.34 -158.42 1 B GLU 5 -48.30 -174.23 1 B ASN 16 -35.38 150.04 1 B ASP 35 -170.20 79.94 1 B ASP 36 -90.02 30.41 1 B ASN 48 -150.24 78.52 1 B PRO 53 -69.80 -169.17 1 B GLU 57 -132.56 -123.45 2 A ALA 2 -106.10 -128.51 2 A ASN 16 -24.98 148.85 2 A VAL 22 -39.90 163.24 2 A ASP 36 -91.74 54.71 2 A PRO 47 -71.35 -156.78 2 A ASP 51 -164.30 112.46 2 A PRO 54 -74.80 -84.08 2 A GLU 57 -101.75 -123.50 2 A CYS 58 -114.39 -70.31 2 A GLU 59 -95.36 -110.25 2 B ALA 2 -127.75 -152.25 2 B PHE 19 -45.02 166.71 2 B ASP 36 -96.81 46.16 2 B PRO 54 -70.01 -135.77 2 B GLU 55 -150.32 -43.11 2 B GLU 56 -121.70 -69.76 2 B CYS 58 -83.23 43.62 2 B GLU 59 -160.30 111.63 3 A ALA 2 -107.68 70.76 3 A ASN 16 -27.63 150.37 3 A VAL 22 -31.56 154.68 3 A ASP 36 -89.62 38.02 3 A VAL 52 -156.71 30.51 3 A GLU 55 -93.14 -157.41 3 A GLU 56 -165.50 -20.18 3 A GLU 59 -145.08 16.66 3 B ALA 2 -96.62 37.24 3 B THR 8 -97.77 55.73 3 B ASN 16 -33.80 150.03 3 B VAL 22 -47.94 158.83 3 B ASP 36 -94.78 46.79 3 B PRO 47 -69.95 -172.42 3 B THR 49 -67.66 80.54 3 B GLU 57 -114.97 60.81 3 B CYS 58 -165.57 32.24 4 A THR 8 -100.30 63.58 4 A ASN 16 -23.48 150.02 4 A VAL 22 -31.58 156.23 4 A ASP 36 -96.68 32.54 4 A GLU 55 -98.51 49.55 4 A CYS 58 -144.49 -4.20 4 A GLU 59 -81.82 -72.70 4 B ALA 2 -73.45 -129.39 4 B ASN 16 -30.01 133.67 4 B PHE 19 -44.83 172.86 4 B VAL 52 -158.46 76.00 4 B PRO 54 -69.57 88.87 4 B GLU 55 -104.56 -119.56 4 B GLU 57 -125.35 -121.20 4 B CYS 58 -123.72 -78.80 5 A ALA 2 -164.13 79.14 5 A THR 8 -69.96 92.14 5 A GLU 13 -109.77 45.60 5 A ASN 16 -23.02 147.06 5 A ASP 35 -159.79 79.94 5 A ASP 36 -80.46 46.00 5 A PHE 45 -124.70 -169.95 5 A PRO 47 -71.17 -158.13 5 A ASN 48 -163.03 102.48 5 A GLU 57 -144.20 -0.61 5 A CYS 58 -72.33 22.09 5 B THR 4 -68.73 -162.47 5 B PRO 11 -39.69 -34.45 5 B ASN 16 -34.36 139.76 5 B VAL 22 -27.70 139.83 5 B GLU 59 -162.06 -46.59 6 A ALA 2 -151.75 30.58 6 A ASN 16 -22.51 148.45 6 A VAL 22 -24.93 150.83 6 A THR 37 -48.71 -7.44 6 A ARG 39 -69.27 -165.50 6 A ASP 51 -161.97 -169.51 6 A GLU 56 -70.77 33.44 6 A CYS 58 -98.99 -106.93 6 A GLU 59 -141.77 -145.78 6 B ASN 16 -32.95 150.06 6 B GLN 26 -39.34 -34.45 6 B ASP 36 -91.83 51.53 6 B ARG 39 -67.98 -178.17 6 B PRO 47 -72.32 -169.87 6 B GLU 55 -95.59 -98.00 6 B GLU 57 -123.47 -120.39 6 B GLU 59 -169.98 -18.10 7 A ASN 16 -35.29 122.02 7 A PHE 19 -44.78 167.87 7 A VAL 22 -49.93 171.03 7 A PHE 45 -122.71 -169.93 7 A PRO 47 -70.87 -156.53 7 A VAL 52 -159.43 67.75 7 A GLU 55 -134.43 -81.01 7 B THR 4 -117.24 -159.92 7 B ASN 16 -24.36 138.13 7 B VAL 22 -49.66 161.20 7 B TYR 46 -46.81 150.57 7 B GLU 55 -124.73 -164.99 7 B GLU 59 -152.01 -33.88 8 A GLU 5 -61.50 -174.92 8 A PRO 11 -46.92 -74.61 8 A GLU 13 -89.66 35.71 8 A ASN 16 -30.31 150.31 8 A VAL 22 -26.21 152.84 8 A ASP 36 -78.18 21.54 8 A PRO 47 -61.02 -150.74 8 A GLU 56 -163.44 -2.62 8 A GLU 57 -141.23 -136.61 8 A CYS 58 -94.50 -70.56 8 A GLU 59 -143.67 14.11 8 B ASN 16 -32.64 140.07 8 B GLN 26 -50.04 -72.85 8 B PRO 54 -70.35 -84.06 8 B GLU 55 -165.34 -167.21 8 B GLU 56 -102.79 -141.19 9 A CYS 7 -146.50 19.38 9 A THR 8 -100.22 63.16 9 A ASN 16 -24.92 150.08 9 A PRO 47 -73.35 -156.70 9 A GLU 55 -132.32 -38.33 9 A GLU 56 -97.35 -75.34 9 A GLU 59 -84.45 -87.45 9 B PRO 47 -69.40 -170.58 9 B PRO 54 -70.09 -110.67 9 B GLU 55 -164.22 -152.37 9 B GLU 57 -143.47 -14.18 9 B CYS 58 -88.75 -137.54 10 A THR 4 -170.44 -159.91 10 A CYS 7 -143.19 -2.30 10 A ASN 16 -27.70 150.32 10 A VAL 22 -30.34 155.04 10 A ASP 35 -155.72 79.84 10 A ASP 36 -88.18 40.50 10 A PRO 47 -80.85 -156.53 10 A PRO 54 -71.01 -121.62 10 A GLU 55 -151.61 -138.19 10 B ARG 14 -63.29 94.98 10 B ASN 16 -23.61 149.76 10 B VAL 22 -37.86 153.06 10 B PRO 47 -62.80 -173.48 10 B VAL 52 -155.21 23.88 10 B GLU 55 -119.98 -164.42 10 B GLU 56 -94.73 -139.77 10 B GLU 59 -105.15 -71.50 PS2 PROTEIN NMR SOLUTION STRUCTURE OF THE DISULPHIDE-LINKED HOMODIMER OF HUMAN TFF1, 10 STRUCTURES 1 N N 1 N N A THR 23 A THR 23 HELX_P A LYS 30 A LYS 30 1 1 8 B THR 23 B THR 23 HELX_P B LYS 30 B LYS 30 1 2 8 disulf 2.028 A CYS 7 A SG CYS 7 1_555 A CYS 33 A SG CYS 33 1_555 disulf 2.031 A CYS 17 A SG CYS 17 1_555 A CYS 32 A SG CYS 32 1_555 disulf 2.030 A CYS 27 A SG CYS 27 1_555 A CYS 44 A SG CYS 44 1_555 disulf 2.030 A CYS 58 A SG CYS 58 1_555 B CYS 58 B SG CYS 58 1_555 disulf 2.029 B CYS 7 B SG CYS 7 1_555 B CYS 33 B SG CYS 33 1_555 disulf 2.028 B CYS 17 B SG CYS 17 1_555 B CYS 32 B SG CYS 32 1_555 disulf 2.030 B CYS 27 B SG CYS 27 1_555 B CYS 44 B SG CYS 44 1_555 GROWTH FACTOR GROWTH FACTOR, CELL MOTILITY, TUMOR SUPPRESSOR, TREFOIL DOMAIN PS2_HUMAN UNP 1 P04155 25 84 1HI7 1 60 P04155 A 1 1 60 25 84 1HI7 1 60 P04155 B 1 1 60 2 2 2 2 anti-parallel anti-parallel anti-parallel anti-parallel A THR 4 A THR 4 A THR 6 A THR 6 A ASN 48 A ASN 48 A ILE 50 A ILE 50 A CYS 33 A CYS 33 A PHE 34 A PHE 34 A CYS 44 A CYS 44 A PHE 45 A PHE 45 B THR 4 B THR 4 B THR 6 B THR 6 B ASN 48 B ASN 48 B ILE 50 B ILE 50 B CYS 33 B CYS 33 B PHE 34 B PHE 34 B CYS 44 B CYS 44 B PHE 45 B PHE 45 1 P 1